Uniting The European & International Anti-RAS Drug Development Community From Large Pharma, Innovative Biotech & KOLs Of Academia

With the diversity of therapeutic approaches to target RAS family of proteins growing rapidly and following the recent clinical progression of highly optimistic candidates, the  RAS- Targeted Drug Discovery Summit Europe is coming to Vienna to showcase a full array of approaches to finally drug the “undruggable” RAS family of proteins. As part of a series of industry dedicated and translational focused meetings focused solely on anti-RAS drug discovery, this summit will be your opportunity to:


HEAR from the leaders of the European and international anti-RAS drug discovery community as they develop diverse tools and approaches to tackle the undruggable nature of RAS


GAIN first-hand insights on challenges and strategies on how to robustly translate promising RAS inhibitors into clinical development and increase your success rate


FORM lasting connections by engaging directly with colleagues from the leading pharma and biotech companies actively developing anti-RAS therapies and seeking the best solutions, in an intimate environment

Companies In Attendance Included

Who Will You Meet?